Year-over-year earnings per share growth for the last twelve months: Opthea (OPT)

Public company logo of Opthea Corp (OPT)

Opthea Limited is deploying its accumulated capital toward final clinical trials, creating a temporary liquidity shortfall. Meanwhile, the development of macular degeneration treatments guarantees stable demand due to the requirement for lifelong treatment. On GURU.Markets, the quarterly EPS variation clearly demonstrates market expectations, where the 28.70 metric indicates the profitability status. Global patents ensure high margins and seamless scaling of biologic production.

Opthea Ltd (OPT) Year-over-year net earnings per share trend for the last twelve months: for the period 07/04/2022 - 06/28/2025

Opthea Corp (OPT) - metric breakdowns and financial figures

- market value and analyst target forecast:
Price Chart Opthea|OPT - Analyst Median Target
- company stock exchange capitalization indicators:
Market Value Opthea Ltd.|OPT - Total Enterprise Value
- book capitalization data:
Net Assets per Single Share Opthea|OPT - Net Asset Value|Market Cap to Net Assets Ratio opthea.com|OPT - Aggregate Business Assets
- company liabilities and liquidity data:
Total Debt to Capital Opthea Limited|OPT - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Opthea Limited|OPT - Company Cumulative Debt|Debts to Book Capitalization Opthea Ltd.|OPT - Company Long-Term Debts|Company Current Liabilities Opthea|Quick Liquidity opthea.com
- earnings and market multiples details:
OPT - Company Net Income|Projected Future Earnings Opthea Limited|OPT - Business Payback Period|Future Price to Earnings Opthea Ltd.|OPT - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Opthea Ltd.|OPT - Operating income before deduction of amortization|Net earnings per share for the last 12 months Opthea|OPT - Earnings per share for the last four quarters|Quarterly EPS earnings growth opthea.com|OPT - Earnings per share growth rate in current year|Earnings growth forecast for next year Opthea Limited
Comprehensive company analysis:Opthea - OPT
Flagship merchandise of Opthea Corp

The specifics of clinical trials for macular degeneration therapy in partnership with ophthalmology centers directly determine the quarterly dynamics of Opthea Limited (OPT) EPS. This indicator measures the growth rate of net income per share, allowing for an assessment of real capital management efficiency and the business model's sensitivity to market costs, which is critical for avoiding investments at peak valuation.

Competitor analysis

Alcon (ALC) - Year-over-year earnings per share growth for the last twelve months|BLCO - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Glaukos Corp.|Earnings per share growth in annualized terms for the last twelve months Apellis Corp APLS|Year-over-year earnings per share growth for the last twelve months Belite Bio (BLTE)|OCUL: Year-over-year net earnings per share trend for the last twelve months|Harrow - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months VRDN (Viridian Therapeutics Inc)|LENZ Pharma - Quarterly EPS earnings growth|Year-over-year earnings per one share growth for the last 12 months OCS (Oaktree Specialty Lending)|EYPT: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months kodiak.com (KOD)|ALDX (Aldeyra Therapeutics Inc.) - Quarterly EPS earnings growth|Quarterly EPS earnings growth Kala Pharmaceuticals|Year-over-year net earnings per share growth for the last 12 months IRD (Opus Genetics Inc)|OKYO (okyopharma.com) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Adverum Biotechnologies, Inc. ADVM|outlooktherapeutics.com - Year-over-year earnings per share growth for the last twelve months|Clearside Biomedical, Inc. - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months NovaBay Pharmaceuticals NBY|kiorapharma.com (KPRX) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months Alimera Sciences, Inc.|EYEN (Eyenovia Inc.) - Quarterly EPS earnings growth|guardionhealth.com (GHSI) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months OCUP (Ocuphire Pharma)